HEPATIC METASTASES - 09/09/11
Riassunto |
Metastatic disease involving the liver represents one of the most common problems in oncology. The liver provides a fertile soil for metastases, not only due to its dual blood supply from both systemic and splanchnic systems, but also because of the presence of humoral factors promoting cell growth, and the discontinuous nature of the endothelial lining of the hepatic sinusoid allowing open communication with the extracellular space of Disse.6 The liver is second only to regional lymph nodes as a site of metastatic disease. The true prevalence of metastatic disease is unknown, because most figures are based on autopsy series that reflect the end stage of a disease process, but between 30% and 70% (depending on the primary tumor) of patients who die of cancer have liver metastases at autopsy.31 Although the presence of liver metastases is never a good prognostic indicator, the use of more aggressive treatment regimes in certain patient subsets can result in a favorable outcome.6
Developments in imaging techniques, notably ultrasound, CT scan, and MR imaging, occurring over the last two decades have dramatically increased our ability to detect and characterize focal liver lesions, and have seen the liver become the primary focus of interest in abdominal imaging.
Il testo completo di questo articolo è disponibile in PDF.Mappa
| Address reprint requests to Pablo R. Ros, MD, Harvard Medical School, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02215 |
Vol 36 - N° 2
P. 349-363 - marzo 1998 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
